Trial Profile
A Prospective, Multicenter Study, to Evaluate the Efficacy and Safety of [18F]-ML-10, a PET Imaging Radiotracer, in Early Detection of Response of Non-Hematological Tumors to Concurrent Chemoradiotherapy
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 27 Feb 2017
Price :
$35
*
At a glance
- Drugs Fluorine-18 ML 10 (Primary)
- Indications Head and neck cancer; Non-small cell lung cancer
- Focus Diagnostic use
- Sponsors Aposense
- 04 Apr 2014 New trial record